![Gabriela Kramer-Marek: I have just presented the very first results of our recently initiated clinical study evaluating 89Zr-DFO-Atezolizumab in patients with newly diagnosed glioblastoma!](https://oncodaily.com/pub/uploads/2023/09/Gabriela-Kramer-Marek-f-1280x1280.jpeg)
Photo taken from Gabriela Kramer-Marek/LinkedIn
Sep 19, 2023, 20:03
Gabriela Kramer-Marek: I have just presented the very first results of our recently initiated clinical study evaluating 89Zr-DFO-Atezolizumab in patients with newly diagnosed glioblastoma!
Gabriela Kramer-Marek, Associate Professor, Reader in Molecular Imaging at The Institute of Cancer Research, London, shared on LinkedIn:
“EANM 2024, Vienna.
I have just presented the very first results of our recently initiated clinical study evaluating 89Zr-DFO-Atezolizumab in patients with newly diagnosed glioblastoma!
I am really happy we did it and NIO Gliwice, Poland and ICR, London UK ”
Source: Gabriela Kramer-Marek/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 6, 2024, 18:00